In our previous study on HCC, MeCP2 combined with CREB1 to promote the expression of HOXD3 by binding to the promoter hypermethylation region of HOXD3 in vivo and in vitro [8]. This evidence concerns the gene HOXD3 and hepatocellular carcinoma.